including the CEO, Chief Operating Officer, and Senior Vice President. He joined Endo in 2015 as the Senior Vice President, Global Quality and Compliance for Par Pharmaceutical, following Endo’s acquisition of Par. and its subsidiary Endo Pharmaceuticals Inc. Barbarite brings over 35 years of pharmaceutical quality and compliance experience covering both generic and branded organizations. Barbarite is Executive Vice President, Global Quality and Compliance effective November 2016. Tayi completed his medical degree at UFHEC, Dominican Republic, his residency and fellowship at Baylor - Scott and White in Temple, Texas and his Master of Public Health at Texas A&M University. He joined Endo in 2015 as the Senior Vice President, Global Quality and Compliance for Par Pharmaceutical, following Endo’s acquisition of Par. His experience spans across medical therapeutics, gene therapies, vaccines, sterile injectables, diagnostics, medical devices and generics across multiple therapeutic areas.ĭr. Tayi has held a variety of lead senior medical officer positions at Endo Pharmaceuticals, Ferring Pharmaceuticals, Mallinckrodt Pharmaceuticals/Ikaria, Optimer Pharmaceuticals/Cubist, Archimedes Pharma, Merck and Schering Plough. Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology. Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Tayi, has over 20 years of diverse experience, including US and global pharmaceuticals industry experience in direct and matrix organizations with knowledge and expertise across all functions within research and development, global medical affairs, and portfolio management. Craven,Vice President,Corporate Compliance & BusinessPractices, Endo Pharmaceuticals Margaret K. Endo Pharmaceuticals 6,955 followers on LinkedIn.
As an executive, he leads American Regent teams with responsibilities for global drug development, drug safety and surveillance, medical affairs and quantitative sciences.ĭr. McGuinness has responsibility for the Company’s overall global quality and compliance. Ravi Tayi, MD, MPH., is Vice President and Chief Medical Officer at American Regent, Inc., a Daiichi Sankyo Group Company. EMEA, HC and ROW regulatory and quality strategies supporting development and preparation of drug products, investigational studies. Michael (Mick) McGuinness was appointed Global Head of Quality and Compliance, effective June 2022.
0 kommentar(er)
